Genome editing is increasingly recognzed as a leading frontier in biomedical research and an essential driver of healthcare innovation. At City University of Hong Kong (CityUHK), a research team has ...

The project team led by Professor Zheng Zongli (right) of CityUHK’s Department of Biomedical Sciences, will focus on liver and cardiovascular genetic diseases, harnessing state-of-the-art “DNA surgery ...

By using a patient's DNA to craft personalized drug treatments, doctors can increase the efficacy and better the outcomes of ...

Assessment of ovarian function suppression (OFS)-containing adjuvant endocrine therapy in premenopausal women by Breast Cancer Index. HR: hormone receptor, HER2: human epidermal growth factor receptor ...